Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD46 and Oncologic Interactions: Friendly Fire against Cancer

Antibodies(2020)10.3390/antib9040059Source: DataRank Database

CD46 and Oncologic Interactions: Friendly Fire against Cancer is a research paper published in Antibodies (2020). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 5.14)OA: goldTopics (32)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

M. Kathryn Liszewski ORCID,John P. Atkinson ORCID,Michelle Elvington ORCID

Live enrichment

PubMed:33147799 PMC:PMC7709105 OpenAlex:https://openalex.org/W3096429767

Foundation for the National Institutes of Health

Grant: R35-GM136352 and 2R01-GM99111-23

National Institutes of Health

Grant: R35-GM136352-01 and 2R01-GM99111-23

NIGMS NIH HHS

Grant: R35 GM136352

NIGMS NIH HHS

Grant: R01 GM099111

National Institutes of Health

Grant: 5R35GM136352-05

Defining the Complosome in Human Cells, Tissues and Disease States

National Institutes of Health

Grant: 5R01GM099111-23

INTRACELLULAR C3 PROTEINS: SOURCE, COMPOSITION, TRAFFICKING AND FUNCTION

FWCI

5.14

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4468/9/4/59/pdf?version=1604380852

publisherhttps://www.mdpi.com/2073-4468/9/4/59/pdf?version=1604380852

publisherhttps://www.mdpi.com/2073-4468/9/4/59/pdf

journalhttps://doi.org/10.3390/antib9040059

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33147799

Fields of Study

Virus-based gene therapy researchAnimal Virus Infections Studiesinterferon and immune responses0301 basic medicine03 medical and health sciences

Keywords

CD46Oncolytic virusBiologyCancer researchCancerCancer cellImmunotoxinMeasles virusImmunosurveillanceVirologyMonoclonal antibodyVirusComplement systemImmunologyAntibodyVaccinationMeaslesGeneticsTumor cellsComplementAdenovirusCancer TherapeuticsAntibody-drug ConjugatesMembrane Cofactor Protein (Mcp)ReviewImmunologic diseases. AllergyRC581-607

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129368.v1figshare

Additional file 1 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129368figshare

Additional file 4 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129377.v1figshare

Additional file 4 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129377figshare

Additional file 2 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129371figshare

Additional file 3 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129374.v1figshare

Additional file 3 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129374figshare

Additional file 2 of A novel approach for breast cancer treatment: the multifaceted antitumor effects of rMeV-Hu191

10.6084/m9.figshare.27129371.v1figshare

CD46 and Oncologic Interactions: Friendly Fire against Cancer

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Linked Datasets (8)

Annotations (Europe PMC)